USPTO serial 79316573
VC VISION CARE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 17, 2023
- Examiner
- VAGHANI, MAYUR C
- Law office
- TMO LAW OFFICE 124
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with VC VISION CARE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Kobe-shi, Hyogo, JP
Kobe-shi, Hyogo, JP
Kobe-shi, Hyogo, JP
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sandra Epp Ryan
Sandra Epp Ryan HAMRE, SCHUMANN, MUELLER & LARSON, P.C.45 South Seventh Street, Suite 2700Minneapolis, MN 55402UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Stem cells for medical purposes; living cells for medical use; cells for medical use; biological tissue cultures for medical purposes; cultures of microorganisms for medical purposes; preparations of microorganisms for medical use; nutritive substances for microorganism cultures; media for bacteriological cultures; media for microorganisms for medical purposes; surgical implants grown from stem cells; enzymes for medical purposes; oxygen for medical purposes; reagents for use in medical genetic testing; chemical reagents for medical purposes; diagnostic reagents for medical use; reagents for medical use; diagnostic preparations for medical purposes; pharmaceutical preparations for treatment of eye disease and conditions; reagent paper for medical purposes; oiled paper for medical purposes; adhesive tapes for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; sanitary tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid bandages for skin wounds; breast-nursing pads; cotton swabs for medical use; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes | ACTIVE | — |
| 042 | Research or development services in the field of gene therapy; testing or inspection services of treatment methods and pharmaceutical preparations for gene therapy; scientific consultancy and information services relating to testing, inspection, research or development services of methods of treatment of eye diseases and conditions and pharmaceutical preparations used for treatment of eye diseases and conditions for gene therapy; testing or inspection services of treatment methods and pharmaceutical preparations for gene editing, gene modulation, gene targeting; scientific consultancy and information services relating to testing, inspection, research or development services of methods of treatment of eye diseases and conditions and pharmaceutical preparations used for treatment of eye diseases and conditions for gene editing, gene modulation, gene targeting; scientific research in the field of genetics and genetic engineering; testing, inspection, research or development services in the field of pharmaceuticals; testing, inspection, research or development services in the field of cosmetics or foodstuffs; scientific consultancy and information services relating to testing, inspection, research or development services in the field of pharmaceuticals; scientific consultancy and information services relating to testing, inspection, research or development services in the field of cosmetics or foodstuffs; testing, inspection, research or development services in the field of medical treatment methods and techniques; scientific consultancy and information services relating to testing, inspection, research or development services in the field of medical treatment methods and techniques; medical research or development services; testing or inspection services in the medical field in nature of testing and inspection of methods of treatment of eye disease and conditions and pharmaceutical preparations used for treatment of eye diseases and conditions; scientific consultancy and information services relating to testing, inspection, research or development services in the medical fields of eye diseases and conditions, pharmaceuticals and genetics; research or development services in the field of chemistry; testing or inspection services in nature of development of chemical production methods; scientific consultancy and information services relating to testing, or inspection in nature of development of chemical production methods, and research or development services in the field of chemistry; design or development of cell culture apparatus, medical diagnostic apparatus, laboratory apparatus and instruments, testing apparatus and instruments and medical apparatus and instruments; scientific consultancy and information services relating to design or development of cell culture apparatus, medical diagnostic apparatus, laboratory apparatus and instruments, testing apparatus and instruments and medical apparatus and instruments; designing of machines, apparatus, instruments or systems composed of such machines, apparatus and instruments; computer software design; computer programming; maintenance of computer software; consultancy and information services relating to computer programming; consultancy and information services relating to computer software design; consultancy and information services relating to maintenance of computer software; rental of computers; providing temporary use of non-downloadable computer programs on data networks for use in scientific investigations for medical purposes; design services; rental of laboratory apparatus and instruments; rental of testing apparatus and instruments, not for medical purposes in nature of testing and analyzing chemical and biological substances for the presence, absence, or quantity of target chemicals; rental of measuring machines and instruments; rental of testing machines and instruments for testing, inspection, research, or development of methods of treatment of eye diseases and conditions and pharmaceutical preparations used for treatment of eye diseases and conditions; rental of electric or magnetic meters and testers for testing, inspection, research, or development of methods of treatment of eye diseases and conditions and pharmaceutical preparations used for treatment of eye diseases and conditions; rental of measuring apparatus; testing, inspection or research on agriculture, livestock breeding or fisheries; research services in the field of laboratory apparatus and instruments; testing services in the field of laboratory apparatus and instruments in nature of testing, inspection, research, or development of methods of treatment of eye diseases and conditions and pharmaceutical preparations used for treatment of eye diseases and conditions; scientific consultancy and information services relating to testing or research services in the field of laboratory apparatus and instruments; research services in the field of testing apparatus and instruments, not for medical purposes; testing services in the field of testing apparatus and instruments, not for medical purposes, used for testing, inspection, research, or development of methods of treatment of eye diseases and conditions and pharmaceutical preparations used for treatment of eye diseases and conditions; testing or research services in the field of testing the functionality of testing apparatus and instruments for medical purposes; scientific consultancy and information services relating to testing or research services in the field of testing apparatus and instruments, not for medical purposes; scientific consultancy and information services relating to testing or research services in the field of testing the functionality of testing apparatus and instruments for medical purposes; testing or research services in the field of medical apparatus and instruments; consultancy and information services relating to testing or research services in the field of medical apparatus and instruments; testing or research on functionality of machines, apparatus and instruments; scientific laboratory services; conducting technical project studies, namely, conducting scientific feasibility studies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Vision Care Inc.
- Other trademarks owned by Vision Care Inc.
- Other trademarks owned by Vision Care Inc.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named VC VISION CARE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 14, 2024 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Apr 6, 2024 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Mar 25, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 9, 2023 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| May 23, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 27, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 26, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 17, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 23, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 17, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 17, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 4, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 4, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 1, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 1, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 1, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 12, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 12, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 12, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 27, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 30, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 30, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 30, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 27, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 9, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 9, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 11, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 10, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 7, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 10, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 6, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 29, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |